00927nas a2200325   4500000000100000008004100001260001300042653002900055653004400084653001600128653001700144653003300161653002100194653001100215653003000226653002900256653002300285653001200308653002500320653003900345653001700384653001500401653001600416100001200432245008300444856004300527300001000570490000700580022001400587       1996                            d  c1996 Dec10aAnti-Inflammatory Agents10aAnti-Inflammatory Agents, Non-Steroidal10aClofazimine10aCyclosporine10aDrug Administration Schedule10aErythema Nodosum10aHumans10aHypersensitivity, Delayed10aImmunosuppressive Agents10aLeprostatic Agents10aleprosy10aLeprosy, lepromatous10aPeripheral Nervous System Diseases10aPrednisolone10aPrednisone10aThalidomide1 aNaafs B00aBangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.  uhttp://ila.ilsl.br/pdfs/v64n4s1a01.pdf  aS21-80 v64  a0148-916X